Skip to main content
L&K BIOMED CO., LTD. logo

L&K BIOMED CO., LTD. — Investor Relations & Filings

Ticker · 156100 ISIN · KR7156100000 KO Manufacturing
Open in API
Filings indexed 358 across all filing types
Latest filing 2025-05-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 156100

About L&K BIOMED CO., LTD.

https://www.lnkbiomed.com

L&K BIOMED CO., LTD. is a global medical device company specializing in the development, manufacturing, and marketing of orthopedic spinal implants. The company's product portfolio is designed to treat a variety of spinal diseases and includes solutions such as the Anterior Cervical Plate System, Posterior Cervical Screw System, and Cervical Cage Systems. With a strong emphasis on research and development, L&K BIOMED focuses on creating innovative and high-quality technologies to advance spinal health and contribute to the broader medical industry.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a private placement of convertible bonds) by L&K Biomed. It details the issuance amount, payment date, and confirms the completion of the transaction. This falls under the category of capital and financing updates, specifically related to the issuance of debt/equity instruments.
2025-05-28 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). This is a specific corporate action related to capital structure and debt management. Since it details the repurchase of debt instruments (convertible bonds) by the company, it falls under the 'Capital/Financing Update' category, as it directly impacts the company's outstanding debt and capital structure.
2025-05-26 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This document outlines the terms of the issuance, including interest rates, conversion prices, call/put options, and the purpose of the funds. This falls under the category of capital and financing updates.
2025-05-26 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the first quarter of 2025 (제18기 1분기) for L&K Biomed Co., Ltd. It contains detailed financial data, management discussion, and operational information, which fits the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, director appointments, and voting outcomes for various agenda items. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-21 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is a '사업보고서 (정정신고)' (Business Report - Amendment) filed by L&K BIOMED. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year 2024. Although it is an amendment, it functions as the primary annual financial disclosure document (10-K equivalent in the Korean market). FY 2024
2025-03-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.